ZS
Zoya Siddiqui
Credentials:
History
- 2026–2029
- 2022–2026
Medical School
Research
New Oral PCSK9 Inhibitor: "MK-0616"
Review · Cardiology in Review · 2025 · First of 2 authors · 10 citations
A Review of Sotagliflozin: The First Dual SGLT-1/2 Inhibitor
Review · Cardiology in Review · 2026 · First of 4 authors · 9 citations
SGLT-2 Inhibitors: Focus on Dapagliflozin
Review · Cardiology in Review · 2026 · First of 3 authors · 4 citations
4 papers
2 papers · 2 as a resident
- AW
1 paper
1 paper · 1 as a resident
- EF
1 paper · 1 as a resident
1 paper
- NR
1 paper · 1 as a resident
1 paper